article thumbnail

Routine ECG screening may help to prevent cardiovascular disease events in adults

Medical Xpress - Cardiology

Routine electrocardiogram (ECG) screening may help to prevent cardiovascular disease (CVD) events, according to a study published online July 1 in JAMA Internal Medicine.

article thumbnail

Spotlight on early detection of three heart diseases using ECG-AI

Medical Xpress - Cardiology

Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest.

article thumbnail

A novel approach for denoising electrocardiogram signals to detect cardiovascular diseases using an efficient hybrid scheme

Frontiers in Cardiovascular Medicine

BackgroundElectrocardiogram (ECG) signals are inevitably contaminated with various kinds of noises during acquisition and transmission.

article thumbnail

AliveCor's Kardia 12L ECG System Receives Category III CPT Codes

DAIC

Our AI-powered, portable Kardia 12L is AliveCor's first device developed exclusively for use by healthcare providers, paving the way to bring this clinically-validated ECG technology to patients anytime and anywhere."

article thumbnail

Cardiovascular disease development in COVID-19 patients admitted to a tertiary medical centre in Iran

The British Journal of Cardiology

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG).

article thumbnail

AI detects systolic heart failure from wearable devices

Medical Xpress - ECG

Wearable devices often pick up noisy electrocardiograms (ECGs), which can hinder artificial intelligence (AI)-based detection of cardiovascular disease.

article thumbnail

Abstract 4142589: GLP-1 receptor agonists slow the progression of subclinical cardiovascular risk as detected from 12-lead electrocardiograms

Circulation

Background:GLP-1 receptor agonists (GLP1RA) agonists have been shown to reduce cardiovascular events in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD). However, it is unclear whether early subclinical therapeutic changes can be detected from routine 12-lead electrocardiograms (ECGs).Methods:We